EUR m | 12M 2022 | 12M 2021 |
Revenue | 1,771.9 | 1,627.3 |
EBITDA (adjusted) | 541.4 | 513.3 |
Exceptional items | 0.8 | -5.9 |
EBITDA | 542.2 | 507.3 |
Amortization, depreciation and impairment | -303.5 | -310.1 |
thereof attributable to purchase price allocations and impairment losses | -27.3 | -45.9 |
EBIT | 238.7 | 197.3 |
Net financial income/costs | -27.9 | -28.6 |
EBT | 210.8 | 168.7 |
Taxes | -59.0 | -38.5 |
Consolidated profit or loss for the period | 151.8 | 130.3 |
Adjusted consolidated profit or loss for the period | 171.5 | 170.2 |
Free cash flow (before M&A transactions) | 248.3 | 325.1 |
Net debt ( 31 Dec) | 718.0 | 612.3 |
1For further details on the individual financial figures, please refer to the section “Value-based management” |
In EUR m | Q2 2023 | Q2 2022 | 6M 2023 | 6M 2022 |
Revenue | 454.8 | 425.0 | 864.7 | 810.0 |
EBITDA (adjusted) | 130.0 | 125.7 | 227.2 | 220.3 |
Exceptional items | -1.5 | 11.5 | -4.3 | 8.2 |
EBITDA | 128.6 | 137.1 | 222.9 | 228.4 |
Amortization, depreciation and impairment | -76.7 | -75.5 | -152.7 | -146.3 |
thereof attributable to purchase price allocations and impairment losses | -4.8 | -6.7 | -9.8 | -13.6 |
EBIT | 51.9 | 61.7 | 70.2 | 82.1 |
Net finance income/costs | -14.7 | -6.3 | -28.4 | -12.3 |
EBT | 37.2 | 55.4 | 41.9 | 69.8 |
Taxes | -10.3 | -12.8 | -11.5 | -16.1 |
Consolidated profit or loss for the period | 26.9 | 42.6 | 30.3 | 53.7 |
Adjusted consolidated profit or loss for the period | 31.2 | 39.0 | 40.0 | 58.0 |
Free cash flow (before M&A transactions) | 56.0 | 85.8 | 77.3 | 83.7 |
Net debt (Jun. 30/Dec. 31) | 753.8 | 718.0 |